3/24
06:08 pm
sny
Sanofi (SNY) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
Low
Report
Sanofi (SNY) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
3/24
04:29 pm
sny
Sanofi Autoimmune Pipeline Grows As Market Weighs Valuation And Momentum [Yahoo! Finance]
Low
Report
Sanofi Autoimmune Pipeline Grows As Market Weighs Valuation And Momentum [Yahoo! Finance]
3/24
06:43 am
sny
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody [Yahoo! Finance]
Low
Report
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody [Yahoo! Finance]
3/24
03:08 am
sny
Press release: Availability of the Q1 2026 aide-mémoire [Yahoo! Finance]
Low
Report
Press release: Availability of the Q1 2026 aide-mémoire [Yahoo! Finance]
3/24
02:30 am
sny
Press release: Availability of the Q1 2026 aide-mémoire
Low
Report
Press release: Availability of the Q1 2026 aide-mémoire
3/24
02:00 am
sny
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
Low
Report
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
3/23
08:31 am
sny
Earendil Labs lands $787m to fund biologics development push [Yahoo! Finance]
Low
Report
Earendil Labs lands $787m to fund biologics development push [Yahoo! Finance]
3/23
08:11 am
sny
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment [Yahoo! Finance]
Low
Report
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment [Yahoo! Finance]
3/23
07:09 am
sny
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases [Yahoo! Finance]
Low
Report
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases [Yahoo! Finance]
3/23
12:51 am
sny
Sanofi Deepens Mirecule And Earendil Ties To Shape Rare Disease Future [Yahoo! Finance]
Low
Report
Sanofi Deepens Mirecule And Earendil Ties To Shape Rare Disease Future [Yahoo! Finance]
3/21
07:13 am
sny
Sanofi (SNY) was upgraded by Sanford C. Bernstein to "strong-buy".
Low
Report
Sanofi (SNY) was upgraded by Sanford C. Bernstein to "strong-buy".
3/20
07:57 am
sny
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development [Yahoo! Finance]
Low
Report
Earendil Labs Announces $787 Million in Financing to Scale AI-Driven Biologics Discovery and Development [Yahoo! Finance]
3/19
01:13 pm
sny
Generate Biomedicines IPO Turns Heads [Yahoo! Finance]
Low
Report
Generate Biomedicines IPO Turns Heads [Yahoo! Finance]
3/19
07:32 am
sny
Dupixent's Impact On Sanofi: A Quantitative Projection Of Its Revenue [Seeking Alpha]
Low
Report
Dupixent's Impact On Sanofi: A Quantitative Projection Of Its Revenue [Seeking Alpha]
3/18
07:37 am
sny
Mirecule Expands Strategic FSHD Collaboration with Sanofi [Yahoo! Finance]
Low
Report
Mirecule Expands Strategic FSHD Collaboration with Sanofi [Yahoo! Finance]
3/18
04:11 am
sny
?????????????? - ??????????????????2026-2035? [CNET News]
Low
Report
?????????????? - ??????????????????2026-2035? [CNET News]
3/18
03:14 am
sny
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report [Yahoo! Finance]
Low
Report
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual Report [Yahoo! Finance]
3/18
02:14 am
sny
Press Release: Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease [Yahoo! Finance]
Low
Report
Press Release: Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease [Yahoo! Finance]
3/18
02:00 am
sny
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Low
Report
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
3/17
02:42 pm
sny
Big drugmakers must face US overcharge claims on medications for low-income patients In this article : [Yahoo! Finance Canada]
Low
Report
Big drugmakers must face US overcharge claims on medications for low-income patients In this article : [Yahoo! Finance Canada]
3/17
02:37 pm
sny
Transient but transformative: Sanofi's mRNA CAR-T enters in vivo race [Yahoo! Finance]
Low
Report
Transient but transformative: Sanofi's mRNA CAR-T enters in vivo race [Yahoo! Finance]
3/17
04:32 am
sny
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
3/16
10:11 pm
sny
????????2036??87.0????????CAGR 4.98%????????????? [CNET News]
Low
Report
????????2036??87.0????????CAGR 4.98%????????????? [CNET News]
3/16
11:05 am
sny
Sanofi: An Undervalued Stock For Long-Term Dividend Growth Investors [Seeking Alpha]
Low
Report
Sanofi: An Undervalued Stock For Long-Term Dividend Growth Investors [Seeking Alpha]
3/13
08:36 am
sny
Tenivac (Sanofi Pasteur) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Tenivac (Sanofi Pasteur) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]